These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. Maccari R, Del Corso A, Giglio M, Moschini R, Mura U, Ottanà R. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):200-3. PubMed ID: 21129963 [Abstract] [Full Text] [Related]
10. Discovery of new inhibitors of aldose reductase from molecular docking and database screening. Rastelli G, Ferrari AM, Costantino L, Gamberini MC. Bioorg Med Chem; 2002 May 01; 10(5):1437-50. PubMed ID: 11886806 [Abstract] [Full Text] [Related]
11. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, Staffieri M, Antolini L, Del Corso A, Mura U, Albasini A. J Med Chem; 1999 Jun 03; 42(11):1881-93. PubMed ID: 10354396 [Abstract] [Full Text] [Related]
12. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors. Wu B, Yang Y, Qin X, Zhang S, Jing C, Zhu C, Ma B. ChemMedChem; 2013 Dec 03; 8(12):1913-7. PubMed ID: 24115741 [Abstract] [Full Text] [Related]
13. Synthesis of 4-thiazolidinone analogs as potent in vitro anti-urease agents. Rahim F, Zaman K, Ullah H, Taha M, Wadood A, Javed MT, Rehman W, Ashraf M, Uddin R, Uddin I, Asghar H, Khan AA, Khan KM. Bioorg Chem; 2015 Dec 03; 63():123-31. PubMed ID: 26520885 [Abstract] [Full Text] [Related]